Medical Devices Cuffs Market Size and Share
Market Overview
| Study Period | 2019 - 2030 |
|---|---|
| Market Size (2025) | USD 0.98 Billion |
| Market Size (2030) | USD 1.24 Billion |
| Growth Rate (2025 - 2030) | 4.64% CAGR |
| Fastest Growing Market | Asia Pacific |
| Largest Market | Asia Pacific |
| Market Concentration | Medium |
Major Players
*Disclaimer: Major Players sorted in no particular order Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0. |
|
Medical Devices Cuffs Market Analysis by Mordor Intelligence
The Medical Devices Cuffs Market size is estimated at USD 0.98 billion in 2025, and is expected to reach USD 1.24 billion by 2030, at a CAGR of 4.64% during the forecast period (2025-2030).
Adoption accelerates as hypertension screening programs broaden, AI-capable cuffs enter routine clinical practice, and remote care models shift monitoring beyond hospital walls. Demand concentrates in blood pressure cuffs, where software-driven diagnostic features now differentiate brands, and in disposable formats that align with strict infection-prevention rules. Rapid unit growth from home healthcare and Asia’s expanding middle class offsets structural threats from cuff-less technologies, while reshoring moves protect supply continuity amid geopolitical tension. Competitive positioning increasingly hinges on ISO 81060-2 validation, environmental compliance, and the ability to bundle cloud analytics with hardware, factors that are reshaping the medical devices cuffs market landscape.
Key Report Takeaways
- By product type, blood pressure cuffs held 65.77% of the medical devices cuffs market share in 2024 and are projected to grow at 6.69% CAGR through 2030.
- By usability, disposable cuffs captured 56.39% of the medical devices cuffs market size in 2024 and are advancing at 7.02% CAGR to 2030.
- By end user, hospitals accounted for 43.52% revenue share of the medical devices cuffs market in 2024, while home healthcare is set to post the fastest 7.21% CAGR through 2030.
- By geography, Asia Pacific posted the highest 8.13% CAGR for 2025-2030, whereas North America remained the most significant revenue contributor with 37.64% share of the medical devices cuffs market size in 2024.
Global Medical Devices Cuffs Market Trends and Insights
Drivers Impact Analysis
| Driver | (~) % Impact on CAGR Forecast | Geographic Relevance | Impact Timeline |
|---|---|---|---|
| Rising Global Hypertension and Cardiovascular Disease Burden | +1.2% | Global, with highest impact in Asia-Pacific and developing markets | Long term (≥ 4 years) |
| Growth in Home-Based Care and Remote Patient Monitoring | +0.9% | North America & EU leading, expanding to APAC | Medium term (2-4 years) |
| Infection Control Protocols Favoring Disposable Cuffs | +0.7% | Global, particularly acute in hospital-dense urban markets | Short term (≤ 2 years) |
| Regulatory Push: ISO 81060-2 Compliance Cycle | +0.5% | Global, with EU and North America driving initial adoption | Medium term (2-4 years) |
| Reshoring and Localization of Cuff Manufacturing | +0.4% | North America, EU, with spillover to allied markets | Long term (≥ 4 years) |
| Emergence of AI-Enabled Smart Cuffs | +0.8% | North America & EU early adoption, Asia-Pacific scale deployment | Medium term (2-4 years) |
| Source: Mordor Intelligence | |||
Rising Global Hypertension and Cardiovascular Disease Burden
Hypertension afflicts more than 1 billion adults, yet only 21% achieve controlled readings, according to the 2023 WHO report.[1]World Health Organization, “Global Hypertension Report 2023,” who.int Widening screening programs and HEARTS guidelines that champion at-home measurement keep the medical devices cuffs market on a long-run growth path. Clinical studies show home users gain superior risk control versus clinic-only measurement, prompting payers to reimburse home cuffs. Coupled with ageing populations in high-income economies, these factors cement demand for accurate, validated cuffs across care settings.
Growth in Home-Based Care and Remote Patient Monitoring
Remote patient monitoring now serves nearly 50 million U.S. users, reflecting a structural migration of chronic-disease management into the home.[2]Harvard Health, “Home Blood Pressure Monitoring: Why It’s Helpful,” health.harvard.edu Smartphone-connected cuffs and cloud analytics deliver continuous data flows that bolster clinical insight and cut follow-up visits. Reimbursement expansions by Medicare and private insurers lock in economic incentives, while AI triage algorithms push the medical devices cuffs market toward predictive, not reactive, care delivery. Device makers that merge intuitive design with secure data pipelines capture this rising home-healthcare spend.
Infection Control Protocols Favoring Disposable Cuffs
CDC guidelines issued post-pandemic emphasize reprocessing reusable gear, a process many facilities circumvent by adopting single-use cuffs.[3]Centers for Disease Control and Prevention, “Core Infection Prevention and Control Practices,” cdc.gov Hospitals report lower cross-transmission risk and reduced labour tied to sterilisation when shifting to disposables. FDA-cleared antimicrobial cuffs further boost safety profiles.[4]U.S. Food and Drug Administration, “Antimicrobial Blood Pressure Cuffs 510(k) Summary,” fda.gov While supply-chain disruptions highlighted the logistical simplicity of disposables, sustainability pressures now compel manufacturers to explore biodegradable polymers without sacrificing barrier protection.
Regulatory Push: ISO 81060-2 Compliance Cycle
The Lancet Commission and the European Society of Hypertension require blood-pressure devices to pass ISO 81060-2:2018 validation, impacting more than 3,000 models. Non-compliant products are rapidly losing market access as tenders and guidelines list validated devices only. Although rigorous testing raises costs, compliant manufacturers secure competitive moats and reassure clinicians of accuracy, driving purchasing preference inside the medical devices cuffs market.
Restraints Impact Analysis
| Restraint | (~) % Impact on CAGR Forecast | Geographic Relevance | Impact Timeline |
|---|---|---|---|
| Limited Awareness and Access in Low-Income Regions | -0.6% | Sub-Saharan Africa, rural Asia, Latin America | Long term (≥ 4 years) |
| High Cost of Smart and Digital Cuff Technologies | -0.5% | Global, particularly acute in price-sensitive emerging markets | Medium term (2-4 years) |
| Rapid Adoption of Cuff-less Monitoring Alternatives | -0.8% | North America & EU early adoption, Asia-Pacific following | Medium term (2-4 years) |
| Environmental Regulations Targeting Single-Use Plastics | -0.4% | EU leading, expanding to North America and developed markets | Medium term (2-4 years) |
| Source: Mordor Intelligence | |||
Limited Awareness and Access in Low-Income Regions
Only 54% of hypertensive adults in resource-constrained countries are diagnosed, underscoring access gaps. Capital scarcity keeps manual devices in circulation, while electricity and internet deficits curb smart-cuff uptake. Training shortages hamper correct use and data interpretation, limiting the immediate reach of the medical devices cuffs market despite latent epidemiological need.
Environmental Regulations Targeting Single-Use Plastics
The EU Packaging and Packaging Waste Regulation mandates recyclability from 2026 and phases out PFAS in medical devices, forcing redesign of disposable cuffs. Extended-producer requirements raise lifetime costs and push hospitals to trial reusable or hybrid solutions. Manufacturers must innovate sustainable materials without compromising clinical performance, injecting uncertainty into long-term demand for single-use cuffs.
Segment Analysis
By Product Type: Blood Pressure Cuffs Drive Innovation
Blood pressure cuffs captured 65.77% of the medical devices cuffs market share in 2024 and are projected to expand at 6.69% CAGR through 2030. Their central role in cardiovascular care positions them as the focal point for AI feature integration, as shown by Omron’s AFib-detecting device. Cuffed endotracheal and tracheostomy tubes continue steady uptake within surgical and critical-care pathways, yet they trail the pace set by blood-pressure products.
Demand for validated, algorithm-ready devices shields the blood-pressure segment from immediate disruption while cuff-less wearables finalise ISO 81060-2 pathways. Hybrid designs that blend periodic cuff readings with continuous sensors provide a transition strategy and preserve share inside the medical devices cuffs market. These dynamics maintain the blood-pressure category as both volume and value engine for global suppliers.
Note: Segment shares of all individual segments available upon report purchase
By Usability: Disposable Solutions Gain Momentum
Disposable formats commanded 56.39% of the medical devices cuffs market size in 2024 and will grow 7.02% CAGR to 2030 as infection-prevention protocols remain non-negotiable in high-throughput settings. Lower reprocessing labour and avoidance of cross-contamination underpin hospital preference for single-use products.
Environmental legislation complicates this trajectory, especially in Europe where recyclability rules intensify scrutiny of plastics use. Vendors respond by developing biodegradable fabrics and reusable electronics married to single-use sleeves. These designs aim to balance infection control with sustainability targets, a critical selling point as purchasing committees evaluate total-life costs within the medical devices cuffs market.
By End User: Home Healthcare Transformation
Hospitals retained 43.52% revenue share in 2024, underpinned by high-acuity monitoring needs and bulk purchasing capacity. Yet home healthcare settings are forecast to record 7.21% CAGR, the quickest among end users, as payers reimburse remote monitoring and ageing populations prefer in-home management. Portable, app-linked cuffs now dominate new product pipelines, reflecting manufacturers focus on usability for non-clinical persons.
Clinics and ambulatory surgery centres remain steady purchasers, valuing cost-effective yet validated devices. Nonetheless, rising consumer literacy and expanded coverage for remote services shift the centre of gravity toward patient residences, a structural change that steadily enlarges the medical devices cuffs market nexus beyond institutional walls.
Note: Segment shares of all individual segments available upon report purchase
Geography Analysis
North America generated 37.64% of global revenue in 2024, buoyed by Medicare’s expanding reimbursement for remote monitoring and an installed base of AI-cleared devices led by GE HealthCare’s 80 authorisations. Federal incentives for reshoring saw Becton Dickinson inject USD 10 million into domestic lines, boosting security of supply for critical disposables. The forthcoming Quality Management System Regulation aligning FDA with ISO 13485 is expected to streamline post-2026 exports for compliant U.S. manufacturers.
Asia-Pacific is the fastest-advancing territory, registering 8.13% CAGR as urbanising populations intensify hypertension screening. Japan’s USD 40 billion device market grows 5.5% annually as its ageing society requires frequent cardiovascular monitoring. China’s push for indigenous innovation and broader insurance coverage pulls multinational and domestic brands deeper into tier-2 and tier-3 cities, expanding the addressable medical devices cuffs market.
Europe posts stable mid-single-digit growth, underwritten by MDR enforcement that favours thoroughly validated cuffs. Environmental statutes add cost layers yet spur innovation in recyclable packs. PFAS bans force material re-engineering, creating openings for suppliers of compliant polymers. Emerging regions such as South America and the Middle East & Africa remain underpenetrated but have begun adopting remote patient monitoring pilots, indicating long-run upside.
Competitive Landscape
The medical devices cuffs market is moderately consolidated, with prominent manufacturers accounting for significant global sales. Omron Healthcare leverages FDA-cleared AFib detection to command premium positioning and deepen patient engagement outside hospitals. Teleflex’s EUR 760 million acquisition of BIOTRONIK’s vascular intervention unit broadens its cardiovascular footprint and cross-selling synergies. Becton Dickinson expands syringe and IV-line capacity in Utah to shore up North American availability and align with public-sector sourcing criteria.
Technology edge increasingly defines competitive hierarchy—firms marrying hardware with cloud analytics vault ahead on subscription revenue opportunities and clinician loyalty. ISO 81060-2 validation remains a high barrier to entry, while sustainability credentials emerge as a tie-breaker in tenders, pushing incumbents to invest in green materials. Meanwhile, start-ups in cuff-less wearables attract venture capital yet face lengthier regulatory pathways, allowing established cuff vendors to defend their share even as modality shifts unfold within the medical devices cuffs market.
Medical Devices Cuffs Industry Leaders
-
Omron Healthcare, Inc.
-
Cardinal Health
-
SunTech Medical, Inc.
-
GE Healthcare
-
Teleflex Incorporated
- *Disclaimer: Major Players sorted in no particular order
Recent Industry Developments
- February 2025: Teleflex announced acquisition of BIOTRONIK's Vascular Intervention business for approximately EUR 760 million (USD 825 million), enhancing its interventional portfolio with coronary and peripheral vascular devices. This strategic acquisition strengthens Teleflex's position in the USD 10 billion interventional cardiology market and is expected to drive 6% revenue CAGR starting in 2026.
- November 2024: OMRON Healthcare received FDA De Novo authorization for blood pressure monitors featuring AI-powered AFib detection, achieving 95% sensitivity and 98% specificity in clinical trials. The company plans to launch these monitors in early 2025, representing a significant advancement in home cardiovascular monitoring capabilities.
- May 2024: Gerresheimer announced USD 180 million expansion of its Peachtree City, Georgia facility for medical systems production, adding 18,000 square meters of production space and creating over 400 jobs. This investment underscores the company's commitment to North American market expansion and drug delivery system manufacturing.
- April 2024: OMRON Healthcare received a grant for developing a blood pressure monitor with double cuff structure, representing innovation in measurement accuracy and reliability for clinical applications.
Research Methodology Framework and Report Scope
Market Definitions and Key Coverage
Our study defines the medical devices cuffs market as all single-patient or reusable pressure or occlusion cuffs integrated into diagnostic, airway, vascular, or compression systems, including blood-pressure cuffs, cuffed endotracheal tubes, and tracheostomy cuffs that are factory-built and sold to healthcare settings. We count ex-factory revenues only, making sure distributors' mark-ups are removed so purchasers see a clean manufacturer baseline.
Scope exclusion: tourniquets, bandages, and smart-watch cuff-less sensors are not within scope.
Segmentation Overview
- By Product Type
- Blood Pressure Cuffs
- Cuffed Endotracheal Tubes
- Tracheostomy Tubes
- Other Specialty Cuffs
- By Usability
- Disposable Cuffs
- Reusable Cuffs
- By End User
- Hospitals
- Clinics
- Ambulatory Surgery Centers
- Home Healthcare Settings
- By Geography
- North America
- United States
- Canada
- Mexico
- Europe
- Germany
- United Kingdom
- France
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- Middle East & Africa
- GCC
- South Africa
- Rest of Middle East & Africa
- South America
- Brazil
- Argentina
- Rest of South America
- North America
Detailed Research Methodology and Data Validation
Primary Research
Interviews with biomedical engineers, anesthesiologists, procurement leads, and home-care distributors across North America, Germany, India, and Brazil enabled us to validate hospital cuff replacement cycles, emerging ASP discounts, and regional disposable versus reusable splits, which the desk work could only approximate.
Desk Research
We began by mapping patient-volume indicators and installed equipment bases through freely available datasets issued by the World Health Organization, the CDC's National Center for Health Statistics, Eurostat hospital discharge files, and the United Nations Population Prospects. Trade volumes for HS codes 901890 and 902000 were pulled from UN Comtrade, while infection-control guidelines from the American Heart Association and European Society of Anesthesiology helped us frame disposable uptake. Company 10-Ks and FDA 510(k) summaries were scanned in Dow Jones Factiva and D&B Hoovers to benchmark average selling prices and product launch cadence. These sources are illustrative; many additional publications supported data checks and context building.
Market-Sizing & Forecasting
A top-down patient-cohort model converts hypertensive prevalence, elective surgery counts, and ICU ventilation days into unit demand, which is then priced using verified ASP bands. Select bottom-up roll-ups of listed supplier revenues and sampled hospital purchasing helped fine-tune totals. Key variables like hypertension incidence growth, surgical procedure volume, disposable adoption ratio, currency-adjusted ASP trends, and healthcare expenditure per capita drive the model. Multivariate regression with scenario analysis projects the 2025-2030 path, and gaps in bottom-up inputs are bridged through weighted averages from expert responses.
Data Validation & Update Cycle
Output tables run through variance checks against shipment data, peer benchmarks, and prior editions before a senior analyst signs off. Mordor refreshes the file every twelve months and issues interim tweaks when material events hit.
Why Mordor's Medical Devices Cuffs Baseline Commands Reliability
Published values differ because each firm tweaks product scope, base year, and refresh speed.
Our disciplined inclusion of airway cuffs and removal of channel margins, alongside an annual refresh, yields a steadier reference point.
Benchmark comparison
| Market Size | Anonymized source | Primary gap driver |
|---|---|---|
| USD 0.98 B (2025) | Mordor Intelligence | - |
| USD 0.95 B (2025) | Regional Consultancy A | omits home-care channels and assumes slower disposable shift |
| USD 0.91 B (2024) | Trade Journal B | older base year and limited airway cuff coverage |
| USD 0.70 B (2025) | Global Consultancy C | focuses on blood-pressure cuffs only, excludes airway products |
These comparisons show that Mordor's wider yet clearly documented scope, primary-vetted variables, and timely updates give decision-makers the most balanced, transparent baseline.
Key Questions Answered in the Report
What is the current size of the medical devices cuffs market?
The medical devices cuffs market stands at USD 0.98 billion in 2025 and is forecast to reach USD 1.24 billion by 2030, growing at a 4.64% CAGR.
Which product segment holds the largest share of the medical devices cuffs market?
Blood pressure cuffs lead with 65.77% share in 2024 and are expected to expand at 6.69% CAGR through 2030.
Why are disposable cuffs gaining popularity?
Stringent infection-control standards and reduced reprocessing labour have pushed disposable cuffs to a 56.39% share in 2024, with a 7.02% CAGR projected to 2030.
How is AI influencing the medical devices cuffs industry?
AI enables features such as AFib detection, generating diagnostic insights and positioning smart cuffs as predictive healthcare tools, a key differentiator among leading brands.
Which region is expected to grow fastest?
Asia-Pacific is set to register the highest 8.13% CAGR from 2025-2030, driven by expanding healthcare coverage and rising chronic-disease prevalence.
What regulatory changes are shaping product development?
ISO 81060-2 validation requirements and environmental regulations targeting single-use plastics are steering manufacturers toward more accurate and sustainable cuff designs.
Page last updated on:
